Support services for biostatistical and etiological studies

Ended Definitive Contract Awarded Last action

Contract number
00261200209D261021169
Awardee
Awarding agency
Obligated
$4,918,956

Award facts

Contract value 22% obligated
$21,903,489.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
Not on record
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 28 -$57,446
Other Administrative Action 27 · Modified to administratively change the central point of distribution $0
Funding Only Action 26 $7,000
Funding Only Action 25 $441,000
Funding Only Action 24 $135,000
Funding Only Action 23 $53,000
Funding Only Action 22 $30,000
Funding Only Action 21 $53,000
Funding Only Action 20 $67,000
Funding Only Action 19 $40,000
Funding Only Action 18 $75,000
Funding Only Action 17 $40,000
Funding Only Action 16 $350,000
Funding Only Action 15 $63,000
Funding Only Action 14 $103,000
Other Administrative Action 13 $0
Funding Only Action 12 · Support services for biostatistical and etiologic studies $92,902
Funding Only Action 11 $231,000
Funding Only Action 10 · Support services for biostatistical and etiologic studies $50,000
Other Administrative Action 9 $0
Funding Only Action 8 $150,000
Funding Only Action 7 $126,000
Supplemental Agreement for work within scope 6 $0
Supplemental Agreement for work within scope 5 $0
Supplemental Agreement for work within scope 4 $975,500
Supplemental Agreement for work within scope 3 $300,000
Original award $1,594,000
Show all 27

About this award

Written by GovTribe AI ·

This is a definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract, valued at $21,903,489.00, is for support services related to biostatistical and etiological studies. The contract does not have a set-aside designation. Westat, Inc. has extensive experience working with various federal agencies, providing services such as survey research, data collection and analysis, program evaluation, and information technology solutions. The contract is part of Westat's broader portfolio of federal contracts and grants, which include Indefinite Delivery Vehicles (IDVs) with the NCI, the Centers for Disease Control and Prevention, and other agencies, showcasing the company's ability to provide comprehensive, long-term support across multiple federal research and program evaluation initiatives.

Quick answers

Who was awarded contract 00261200209D261021169?

00261200209D261021169 was awarded to Westat, Inc. by National Cancer Institute (National Institutes of Health) on September 15, 2002.

How much is contract 00261200209D261021169 worth?

The government has obligated $4,918,956 on 00261200209D261021169. Its current value, with exercised options, is $21,903,489.

Was contract 00261200209D261021169 competed?

The extent of competition for 00261200209D261021169 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login